stars 1 stars 2 stars 3

Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and in rare diseases. The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York. Seelos’ common stock is traded on The Nasdaq Capital Market under the symbol "SEEL".

View Top Employees from Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc. Questions

The Seelos Therapeutics, Inc. annual revenue was $2 million in 2024.

Michael Golembiewski is the CFO of Seelos Therapeutics, Inc..

26 people are employed at Seelos Therapeutics, Inc..

Seelos Therapeutics, Inc. is based in New York, New York.

The NAICS codes for Seelos Therapeutics, Inc. are [54, 541, 54192, 541921, 5419].

The SIC codes for Seelos Therapeutics, Inc. are [283, 873, 28, 87].

Top Seelos Therapeutics, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users